DOCSLIB.ORG

Ryan White Part a Formulary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ryan White Part a Formulary Ryan White Part A Formulary Updated ƵŐƵƐƚ 2019 Ryan White Part A Pharmacy Formulary - Updated 8/19/19 Tier 1: In order to access Tier 1, clients must qualify for the Ryan White Part A Program based on eligiblity requirements. Drug Classification Brand Name Generic Name Tier 5-Alpha-Reductase Inhibitors/BPH Avodart Dutasteride 1 Anticoagulant/Factor Xa Inhibitors Xarelto Rivaroxaban 1 Antihyperlipidemic Agents- Dietary Source Omega 3 Alpha-Linoleic Acid 1 Antiinfectives/Antifungal Lamisil Terbinafine 1 Antiinfectives/Antiinflammatory Decadron Dexamethasone 1 Antiinfectives/Antiinflammatory Deltasone Prednisone 1 Antiinfectives/Antiinflammatory Medrol dosepak Methyprednisolone 1 Antiinfectives/Antitubercular Rifamate Isoniazid/Rifampin 1 Antiinfectives/Antitubercular Seromycin Cycloserine 1 Antiinfectives/Antiviral/Antibacterial Achromycin Tetracycline 1 Antiinfectives/Antiviral/Antibacterial Amoxil Amoxicillin 1 Antiinfectives/Antiviral/Antibacterial Augmentin Amoxicillin/Clavulanate Potassium 1 Antiinfectives/Antiviral/Antibacterial Bicillin LA Penicillin Benzath 1 Antiinfectives/Antiviral/Antibacterial Ceftin Cefuroxime 1 Antiinfectives/Antiviral/Antibacterial Cipro Ciprofloxacin 1 Antiinfectives/Antiviral/Antibacterial Cleocin Clindamycin 1 Antiinfectives/Antiviral/Antibacterial Ery-tab Erythromycin base 1 Antiinfectives/Antiviral/Antibacterial Keflex Cephalexin 1 Antiinfectives/Antiviral/Antibacterial Macrodantin Nitrofurantoin 1 Antiinfectives/Antiviral/Antibacterial Omnicef Cefdinir 1 Antiinfectives/Antiviral/Antibacterial PenVK Penicililn VK 1 Antiinfectives/Antiviral/Antibacterial Proloprim Trimethoprim 1 Antiinfectives/Antiviral/Antibacterial Rocephin Ceftriaxone INJ 1 Antiinfectives/Antiviral/Antibacterial Vibramycin Doxycycline 1 Antiinfectives/Other Humatin Paromomycin 1 Antitussives Tessalon Benzonatate 1 Bronchodilator Combinations Dulera Formoterol/Mometasone 1 Cardiac & Anti-Hypertensive/Alpha Blockers Catapres Clonidine 1 Cardiac & Anti-Hypertensive/AlphaBeta Blocker Coreg Carvedilol 1 Cardiac & Anti-Hypertensive/Angiotensin Receptor Blocker (ARB) Avapro Irbesartan 1 Cardiac & Anti-Hypertensive/Antiarrythmic Cordarone Amiiodarone 1 Drug Classification Brand Name Generic Name Tier Cardiac & Anti-Hypertensive/Antiplatelet Plavix Aspirin Clopidogrel *Aspirin may only be dispensed with Clopidogrel 1 Cardiac & Anti-Hypertensive/Beta Blockers Inderal Propranolol 1 Cardiac & Anti-Hypertensive/Beta Blockers Normodyne Labetalol 1 Cardiac & Anti-Hypertensive/Diuretic Aldactone Spironolactone 1 Cardiac & Anti-Hypertensive/Diuretic Bumex Bumetanide 1 Cardiac & Anti-Hypertensive/Diuretic Dyazide HCTZ/Triamterene 1 Cardiac & Anti-Hypertensive/Diuretic HydroDiuril HCTZ 1 Cardiac & Anti-Hypertensive/Nitrates Imdur Isosorbide Mononitrate 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Analgesic Celecoxib Celebrex 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Analgesic Fioricet Butalbitol/Acetaminophen/Caffeine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Analgesic Tramadol Ultram 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic Ativan Lorazepam 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic Restoril Temazepam 1 Autonomic/Antianxiety/Hypnotic Valium Diazepam 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antianxiety/Hypnotic Vistaril,Atarx Hydroxyzine 1 CNS, Anxiety, Psych, Neuro, & Acetazolamide Autonomic/Anticonvulsant Diamox 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Dilantin Phenytoin 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Gabapentin Neurontin 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Klonopin Clonazepam 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Phenobarbital Phenobarbital 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Tegretol Carbamazepine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Topamax Topiramate 1 Drug Classification Brand Name Generic Name Tier CNS, Anxiety, Psych, Neuro, & Autonomic/Anticonvulsant Zarontin Ethosuximide 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antidepressant Bupropion Wellbutrin 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antidepressant Buspar Buspirone 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antidepressant Lithonate Lithium Carb 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antimigraine Imitrex (Oral Only) Sumatriptan 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antiparkinson Sinemet Carbidopa/Levodopa 1 Autonomic/Antipsychotic Haldol Haloperidol 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antipsychotic Thorazine Chlorpromazine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Antipsychotic Trilafon Perphenazine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Misc Cogentin Benztropine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant Flexeril Cyclobenzaprine 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant Lioresal Baclofen 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Muscle Relaxant Soma Carisoprodol 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic Methadone Methadone 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic Morphine MSContin, MSIR 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic Percocet Oxycodone/Acet 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic Percodan Oxycodone/ASA 1 CNS, Anxiety, Psych, Neuro, & Autonomic/Narcotic Analgesic Vicodin,VicodinES Hydrocodone/Acetaminophen 1 Dopaminergic Antiparkinaonism Agents Mirapex Pramipexole 1 Gastrointest/Antacid Mylanta DS Al, Mg, Simethicone 1 Gastrointest/Antidiarrheal Imodium Loperamide Paregoric 1 Gastrointest/Antiemetic Promethazine Suppos Promethazine Suppos 1 Drug Classification Brand Name Generic Name Tier Gastrointest/Antiflatulant Mylicon Simethicone 1 Gastrointest/Antispasmotic Bentyl Dicyclomine 1 Gastrointest/Digestive Enzyme Ultrace MT Pancrealipase 1 Gastrointest/Laxative Colace Docusate sodium 1 Gastrointest/Laxative Fibercon Fiberlax 1 Gastrointest/Laxative Peri-Colace Docusate/Casanth 1 Gastrointest/Misc/Other Carafate Sucralfate 1 Gastrointest/Misc/Other GoLytely/Colyte Polyethylene Glycol Electrolyte 1 Gastrointest/PPI Prevacid Lansoprazole 1 Gonadotropin Releasing Hormones Lupron Leuprolide 1 GYN/OB Lo-Ovral 28 Ethinyl Estradiol/Norgestrel 1 GYN/OB Ortho-Tricyclen 28 Ethinyl Estradiol/Norgestimate 1 GYN/OB Premarin Estrogen Conjugated 1 Medication Administration Pen Needles *for Lantus/Levemir Pen Needles 1 Minerals, Electrolytes/Phosphate Binders Calcium Calcium Acetate 1 Misc/Other Colchicine Colchicine 1 Misc/Other Danazol Danocrine 1 Misc/Other Ditropan Oxybutinin 1 Misc/Other MAGIC Mouthwash MAGIC Mouthwash 1 Misc/Other Normal Saline Sodium Chloride for Irrigation 1 Misc/Other Peridex Oral Rinse Chlorhexidine 12% Solution 1 Misc/Other Pyridium Phenazopyridine 1 Misc/Other Zyloprim Allopurinol 1 Nasal Ocean Nasal Sodium Chloride 1 Nasal Rhinocort Budesonide 1 Ophthalmic Antihistamines and Decongestants Pataday Olopatadine Ophthalmic 1 Ophthalmic/Antibiotic Ciloxin Ciprofloxacin 1 Ophthalmic/Antibiotic Dexacidin Dexamethasone/Neomycin/ Polymyxin B 1 Ophthalmic/Antibiotic E-Mycin Erythromycin 1 Ophthalmic/Antibiotic Neosporin Neo/Poly/Bacit 1 Ophthalmic/Antibiotic Sulamyd Sulfacetamide 1 Ophthalmic/Antibiotic Tobrex Tobramycin 1 Ophthalmic/Betablocker Betoptic S Betaxolol 1 Ophthalmic/Betablocker Timoptic Timolol 1 Ophthalmic/Glaucoma Alphagan Brimonide 1 Ophthalmic/Glaucoma Azopt Brinzolamide 1 Ophthalmic/Glaucoma Cosopt Dorzolamide+Timolol 1 Drug Classification Brand Name Generic Name Tier Ophthalmic/Glaucoma Lumigan Bimatoprost 1 Ophthalmic/Glaucoma Xalatan Latanoprost 1 Ophthalmic/Miotic Pilocar Pilocarpine 1 Ophthalmic/Misc/Other Alomide Lodoxamide 1 Ophthalmic/Misc/Other Tearisol Artificial tears 1 Ophthalmic/Misc/Other Vasocon Naphazoline 1 Ophthalmic/Misc/Other Viroptic Trifluridine 1 Ophthalmic/Steroid FML Fluorometholone 1 Ophthalmic/Steroid Pred Forte Prednisolone 1 Opportunistic Infections (OIs) TMP-SMX ds TMP-SMX ds 1 Otic Cortisporin Neomycin / HC 1 Otic Debrox Carbamide Peroxide 1 Otic Anti-Infectives Vosol Acetic Acid 1 Otic Anti-Infectives Vosol HC Acetic Acid/HC 1 Otic Steroids Cipro HC Ciprofloxacin/Hydrocortisone 1 Respiratory, Cough & Cold Allergy/Antihist/Decongestant Cardec, Cardec DM, Cardec S Carbinoxamine/Pseudoephedrine 1 Respiratory, Cough & Cold Allergy/Antihist/Decongestant Sudafed Pseudoephedrine 1 Respiratory, Cough & Cold Allergy/Antitussive Robitussin Guaifenesin 1 Respiratory, Cough & Cold Allergy/Antitussive Robitussin AC Guaifenesin/Codeine 1 Respiratory, Cough & Cold Allergy/Antitussive Robitussin DAC Guaifen/Codeine/Pseudoephedrine 1 Respiratory, Cough & Cold Allergy/Antitussive Robitussin DM Guaifen/Dextromethorphan 1 Respiratory, Cough & Cold Allergy/BetaAgonist Inhaled Serevent Salmeterol Discus 1 Respiratory, Cough & Cold Allergy/BetaAgonist Oral Ventolin Albuterol tab 1 Respiratory, Cough & Cold Allergy/Other Singulair Montileukast 1 Respiratory, Cough & Cold Allergy/Xanthine Theo-Dur Theophylline 1 Skeletal Muscle Relaxants Robaxin Methocarbamol 1 Topical Antibiotic Bactroban Mupirocin 1 Topical Non-Steroidal Anti-Inflammatories Voltaren (gel) Diclofenac Topical 1 Drug Classification Brand Name Generic Name Tier Topical, Dermatology, Rectal, Lidocaine , Xylocaine Oint, Jelly, Visc, Vaginal/Anaesthetic Patch Xylocaine/Lidocaine 1 Vaginal/Antibacterial Benzagel Erythomycin / Benzoyl perox 1 Topical, Dermatology, Rectal, Vaginal/Antibacterial Cleocin Vag Clindamycin 1 Vaginal/Antibacterial Neosporin Neo/Gramic/Poly 1 Topical, Dermatology, Rectal, Vaginal/Antifungal Kenalog Triamcinolone 1 Topical, Dermatology, Rectal, Vaginal/Antifungal
Load more

Recommended publications
  • FF #93 THC Cancer AIDS.3Rd Ed
    ! FAST FACTS AND CONCEPTS #93 CANNABINOIDS IN THE TREATMENT OF SYMPTOMS IN CANCER AND AIDS L Scott Wilner MD and Robert M Arnold MD Introduction The healing properties of cannabis have been asserted for centuries. Popular claims notwithstanding, there are no data to support the use of marijuana in the treatment of asthma, anxiety, depression, epilepsy, glaucoma, alcohol withdrawal, or infection; and limited data to support using cannabinoids as analgesics. Recent scientific studies of cannabinoids for symptom management have focused on nausea/vomiting and appetite stimulation. Terminology Cannabis sativa is the Indian hemp plant. Marijuana is a psychoactive substance derived from the plant. Cannabinoids are the biologically active compounds in the plant. THC is delta )-9 tetrahydrocannabinol, the major cannabinoid. Dronabinol is synthetic THC and the main ingredient in the Schedule 3 drug Marinol. Nabilone is an engineered THC analog that forms the basis of the Schedule 2 drug Cesamet. Pharmacology Cannabinoids act on cannabinoid receptors: the CB1 receptor in the CNS and on the CB2 receptor localized primarily to immune cells. Dronabinol and nabilone are well absorbed orally, but first pass metabolism and protein binding limit bioavailability. Dronabinol has a faster onset of action (~30 minutes), while nabilone has a longer duration of action (typically 8 – 12 hours, but potentially as long as 24 hours in some patients). Alternative delivery systems – including inhalers, suppositories, and transdermal patches – are being evaluated. Anti-emetic Use Dronabinol and nabilone are FDA approved for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond to conventional antiemetics.
    [Show full text]
  • MSM Cross Reference Antihistamine Decongestant 20100701 Final Posted
    MISSISSIPPI DIVISION OF MEDICAID Antihistamine/Decongestant Product and Active Ingredient Cross-Reference List The agents listed below are the antihistamine/decongestant drug products listed in the Mississippi Medicaid Preferred Drug List (PDL). This is a cross-reference between the drug product name and its active ingredients to reference the antihistamine/decongestant portion of the PDL. For more information concerning the PDL, including non- preferred agents, the OTC formulary, and other specifics, please visit our website at www.medicaid.ms.gov. List Effective 07/16/10 Therapeutic Class Active Ingredients Preferred Non-Preferred ANTIHISTAMINES - 1ST GENERATION BROMPHENIRAMINE MALEATE BPM BROMAX BROMPHENIRAMINE MALEATE J-TAN PD BROMSPIRO LODRANE 24 LOHIST 12HR VAZOL BROMPHENIRAMINE TANNATE BROMPHENIRAMINE TANNATE J-TAN P-TEX BROMPHENIRAMINE/DIPHENHYDRAM ALA-HIST CARBINOXAMINE MALEATE CARBINOXAMINE MALEATE PALGIC CHLORPHENIRAMINE MALEATE CHLORPHENIRAMINE MALEATE CPM 12 CHLORPHENIRAMINE TANNATE ED CHLORPED ED-CHLOR-TAN MYCI CHLOR-TAN MYCI CHLORPED PEDIAPHYL TANAHIST-PD CLEMASTINE FUMARATE CLEMASTINE FUMARATE CYPROHEPTADINE HCL CYPROHEPTADINE HCL DEXCHLORPHENIRAMINE MALEATE DEXCHLORPHENIRAMINE MALEATE DIPHENHYDRAMINE HCL ALLERGY MEDICINE ALLERGY RELIEF BANOPHEN BENADRYL BENADRYL ALLERGY CHILDREN'S ALLERGY CHILDREN'S COLD & ALLERGY COMPLETE ALLERGY DIPHEDRYL DIPHENDRYL DIPHENHIST DIPHENHYDRAMINE HCL DYTUSS GENAHIST HYDRAMINE MEDI-PHEDRYL PHARBEDRYL Q-DRYL QUENALIN SILADRYL SILPHEN DIPHENHYDRAMINE TANNATE DIPHENMAX DOXYLAMINE SUCCINATE
    [Show full text]
  • 2-Bromopyridine Safety Data Sheet Jubilant Ingrevia Limited
    2-Bromopyridine Safety Data Sheet According to the federal final rule of hazard communication revised on 2012 (HazCom 2012) Date of Compilation : July 03 ’ 2019 Date of Revision : February 09 ’ 2021 Revision due date : January 2024 Revision Number : 01 Version Name : 0034Gj Ghs01 Div.3 sds 2-Bromopyridine Supersedes date : July 03 ’ 2019 Supersedes version : 0034Gj Ghs00 Div.3 sds 2-Bromopyridine Jubilant Ingrevia Limited Page 1 of 9 2-Bromopyridine Safety Data Sheet According to the federal final rule of hazard communication revised on 2012 (HazCom 2012) SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier PRODUCT NAME : 2-Bromopyridine CAS RN : 109-04-6 EC# : 203-641-6 SYNONYMS : 2-Pyridyl bromide, Pyridine, 2-bromo-, beta-Bromopyridine, o-Bromopyridine SYSTEMATIC NAME : 2-Bromopyridine, -Pyridine, 2-bromo- MOLECULAR FORMULA : C5H4BrN STRUCTURAL FORMULA N Br 1.2. Relevant identified uses of the substance or mixture and uses advised against 1.2.1. Relevant identified uses 2-Bromopyridine is used as an intermediate in the pharmaceutical industry for the manufacture of Atazanavir (an antiretroviral drug), Carbinoxamine, Chloropyramine, triprolidine (antihistamine drugs), Disopyramide Phosphate (an antiarrythmic drug), Mefloquine (antimalarial drug), Pipradrol (mild CNS stimulant) etc. Uses advised against: None 1.3. Details of the supplier of the safety data sheet Jubilant Ingrevia Limited REGISTERED & FACTORY OFFICE: Jubilant Ingrevia Limited Bhartiagram, Gajraula , District: Amroha, Uttar Pradesh-244223, India PHONE NO: +91-5924-252353 to 252360 Contact Department-Safety: Ext. 7424 , FAX NO : +91-5924-252352 HEAD OFFICE: Jubilant Ingrevia Limited, Plot 1-A, Sector 16-A,Institutional Area, Noida, Uttar Pradesh, 201301 - India T +91-120-4361000 - F +91-120-4234881 / 84 / 85 / 87 / 95 / 96 [email protected] -www.jubilantingrevia.com 1.4.
    [Show full text]
  • Pharmacologic Interventions for Fatigue in Cancer and Transplantation: a Meta-Analysis
    DRUG INTERVENTIONS FOR FATIGUE, Tomlinson et al. REVIEW ARTICLE Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis † † ‡ D. Tomlinson RN MN,* P.D. Robinson MD MSc, S. Oberoi MD, D. Cataudella PsyD CPsych, § || # N. Culos-Reed PhD, H. Davis,* N. Duong,* F. Gibson RN PhD, M. Götte PhD, P. Hinds RN PhD,** †† †† † ‡‡ §§ S.L. Nijhof MD PhD, P. van der Torre, S. Cabral, L.L. Dupuis MScPhm PhD,* and L. Sung MD PhD* ABSTRACT Background Our objective was to determine whether, compared with control interventions, pharmacologic interventions reduce the severity of fatigue in patients with cancer or recipients of hematopoietic stem-cell transplantation (hsct). Methods For a systematic review, we searched medline, embase, the Cochrane Central Register of Controlled Trials, cinahl, and Psychinfo for randomized trials of systemic pharmacologic interventions for the management of fatigue in patients with cancer or recipients of hsct. Two authors independently identified studies and abstracted data. Methodologic quality was assessed using the Cochrane Risk of Bias tool. The primary outcome was fatigue severity measured using various fatigue scales. Data were synthesized using random-effects models. Results In the 117 included trials (19,819 patients), the pharmacologic agents used were erythropoietins (n = 31), stimulants (n = 19), l-carnitine (n = 6), corticosteroids (n = 5), antidepressants (n = 5), appetite stimulants (n = 3), and other agents (n = 48). Fatigue was significantly reduced with erythropoietin [standardized mean difference (smd): –0.52; 95% confidence interval (ci): –0.89 to –0.14] and with methylphenidate (smd: –0.36; 95% ci: –0.56 to –0.15); modafinil (or armodafinil) and corticosteroids were not effective.
    [Show full text]
  • Megestrol Acetate: Drug Information
    Official reprint from UpToDate® www.uptodate.com ©2017 UpToDate® Megestrol acetate: Drug information Copyright 1978-2017 Lexicomp, Inc. All rights reserved. (For additional information see "Megestrol acetate: Patient drug information" and see "Megestrol acetate: Pediatric drug information") For abbreviations and symbols that may be used in Lexicomp (show table) Brand Names: US Megace ES; Megace Oral Brand Names: Canada Megace OS; Megestrol Pharmacologic Category Antineoplastic Agent, Hormone; Appetite Stimulant; Progestin Dosing: Adult Note: Megace ES suspension is not equivalent to other formulations on a mg-per-mg basis. Anorexia or cachexia associated with AIDS: Oral: Suspension: U.S. labeling: Initial: 625 mg daily (of the 125 mg/mL suspension) or 800 mg daily (of the 40 mg/mL suspension); daily doses of 400 mg to 800 mg have been found to be effective Canadian labeling: Usual dose: 400 to 800 mg once daily for at least 2 months Breast cancer, advanced: Oral: Tablet: U.S. labeling: 160 mg per day in divided doses of 40 mg 4 times daily for at least 2 months Canadian labeling: 160 mg or 125 mg/m2 daily (40 mg 4 times daily or 160 mg once daily) for at least 2 months Endometrial cancer, advanced: Oral: Tablet: U.S. labeling: 40 to 320 mg daily in divided doses for at least 2 months Canadian labeling: 80 to 320 mg or 62.5 to 250 mg/m2 daily in divided doses (40 to 80 mg 1 to 4 times daily or 160 to 320mg daily) for at least 2 months Cancer-related cachexia: Canadian labeling: Oral: Tablet: 400 to 800 mg once daily for at least 2 months Cancer-related cachexia (off-label use/dosing in U.S.): Oral: Doses ranging from 160 to 800 mg per day were effective in achieving weight gain, higher doses (>160 mg) were associated with more weight gain (Beller, 1997; Loprinzi, 1990; Loprinzi, 1993; Vadell, 1998); based on a meta-analysis, an optimal dose has not been determined (Ruiz Garcia, 2013) Dosing: Geriatric Use with caution; refer to adult dosing.
    [Show full text]
  • Medication Instructions for Allergy Patients
    MEDICATION INSTRUCTIONS FOR ALLERGY PATIENTS Drugs which contain antihistamine or have antihistaminic effects can result in negative reactions to skin testing. As a result, it may not be possible to properly interpret skin test results, and testing may have to be repeated at a later date. While this list is extensive, it is NOT all inclusive (particularly of the various brand names). Discontinue ALL antihistamines including the following medications seven (7) days prior to skin testing (unless longer time specified): Antihistamines – Generic name (Brand name(s)): Cetirizine (Zyrtec, Zyrtec-D) Hydroxyzine (Vistaril, Atarax) Desloratadine (Clarinex) Levocetirizine (Xyzal) Fexofenadine (Allegra, Allegra-D) Loratadine (Claritin, Claritin-D, Alavert) Diphenhydramine (Aleve PM, Benadryl, Bayer P.M., Benylin, Contac P.M., Doans P.M, Excedrin PM, Legatrin P.M.. Nytol, Tylenol Nighttime, Unisom, Zzzquil) Chlorpheniramine (Aller-Chlor, Allerest, Alka Seltzer Plus, Chlor-Trimeton, Comtrex, Contac, Co-Pyronil, Coricidin, CTM, Deconamine, Dristan, Dura-tap, Naldecon, Ornade Spansules, Rondec, Sinutab, Teldrin, Triaminic, Triaminicin, Tylenol Allergy) Azatadine (Optimine, Trinalin) Doxylamine (Nyquil) Brompheniramine (Bromfed, Dimetane, Dimetapp) Meclizine (Antivert) Carbinoxamine (Clistin, Rondec) Pheniramine Clemastine (Tavist) Phenyltoloxamine (Nadecon) Cyclizine (Marezine) Promethazine (Phenergan) Cyprohepatidine (Periactin) (9 days) Pyrilamine (Mepyramine) Dexbrompheniramine (Drixoral) Quinacrine (Atabrine) Dexchlorpheniramine (Extendryl, Polaramine)
    [Show full text]
  • Antihistamine Therapy in Allergic Rhinitis
    CLINICAL REVIEW Antihistamine Therapy in Allergic Rhinitis Paul R. Tarnasky, MD, and Paul P. Van Arsdel, Jr, MD Seattle, Washington Allergic rhinitis is a common disorder that is associated with a high incidence of mor­ bidity and considerable costs. The symptoms of allergic rhinitis are primarily depen­ dent upon the tissue effects of histamine. Antihistamines are the mainstay of therapy for allergic rhinitis. Recently, a second generation of antihistamines has become available. These agents lack the adverse effect of sedation, which is commonly associated with older antihistamines. Current practice of antihistamine therapy in allergic rhinitis often involves random selection among the various agents. Based upon the available clinical trials, chlorpheniramine appears to be the most reasonable initial antihistaminic agent. A nonsedating antihis­ tamine should be used initially if a patient is involved in activities where drowsiness is dangerous. In this comprehensive review of allergic rhinitis and its treatment, the cur­ rent as well as future options in antihistamine pharmacotherapy are emphasized. J Fam Pract 1990; 30:71-80. llergic rhinitis is a common condition afflicting some­ defined by the period of exposure to those agents to which A where between 15 and 30 million people in the United a patient is sensitive. Allergens in seasonal allergic rhinitis States.1-3 The prevalence of disease among adolescents is consist of pollens from nonflowering plants such as trees, estimated to be 20% to 30%. Two thirds of the adult grasses, and weeds. These pollens generally create symp­ allergic rhinitis patients are under 30 years of age.4-6 Con­ toms in early spring, late spring through early summer, sequently, considerable costs are incurred in days lost and fall, respectively.
    [Show full text]
  • Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014
    Supplementary Online Content Hales CM, Kit BK, Gu Q, Ogden CL. Trends in prescription medication use among children and adolescents— United States, 1999-2014. JAMA. doi:10.1001/jama.2018.5690 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class This supplementary material was provided by the authors to give readers additional informtion about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 eTable. Classification of Prescription Medications Reported by NHANES Participants Aged 0-19 Years From 1999- 2000 to 2013-2014 by Therapeutic Class Therapeutic classes are based on the Lexicon Plus prescription medication database and only those classes reported in the manuscript are listed. ADHD Medications Antiadrenergic Agents, Centrally Acting Clonidine Guanfacine CNS Stimulants Amphetamines Amphetamine Amphetamine; Dextroamphetamine Dextroamphetamine Lisdexamfetamine Methylphenidate or Dexmethylphenidate Dexmethylphenidate Methylphenidate Other CNS Stimulant Pemoline Selective Norepinephrine Reuptake Inhibitor Atomoxetine Antibiotics Cephalosporins Cefadroxil Cephalexin Cefaclor Cefprozil Cefuroxime Loracarbef Cefdinir Cefditoren Cefixime Cefpodoxime Ceftibuten Ceftriaxone Glycopeptide Antibiotics Vancomycin H. Pylori Eradication Agents Amoxicillin; Clarithromycin; Lansoprazole Lincomycin Derivatives Clindamycin Macrolide Derivatives Telithromycin Azithromycin Clarithromycin
    [Show full text]
  • Generic Name Brand Name
    Florida AIDS Drug Assistance Program (ADAP) Formulary MAY 2021 *Indicates controlled substance. Unless otherwise noted, all brands, strengths and dosage forms may be ordered pending wholesaler availability. Brand Name (listed for Generic Name Therapeutic Classification Pharmacologic Classification Antiretroviral drugs only) abacavir (ABC) Ziagen Antiretroviral Nucleoside reverse transcriptase inhibitor (NRTI) abacavir/lamivudine (ABC/3TC) Epzicom Antiretroviral NRTI combo abacavir/lamivudine/zidovudine (ABC/3TC/AZT) Trizivir Antiretroviral NRTI combo atazanavir (ATV) Reyataz Antiretroviral Protease inhibitor (PI) atazanavir/cobicistat (ATV/COBI) Evotaz Antiretroviral PI/PK Enhancer bictegravir/emtricitabine/tenofovir alafenamide Biktarvy Antiretroviral INSTI/NRTI combo (BIC/TAF/FTC) cabotegravir Vocabria Antiretroviral INSTI Non-nucleoside reverse transcriptase inhibitor (NNRTI) cabotegravir/rilpivirine (CBV/RPV) Cabenuva Antiretroviral and INSTI cobicistat (COBI) Tybost Antiretroviral Pharmacokinetic enhancer darunavir (DRV) Prezista Antiretroviral Protease inhibitor (PI) darunavir/cobicistat (DRV/COBI) Prezcobix Antiretroviral PI/PK Enhancer darunavir/cobicistat/emtricitabine/tenofovir Symtuza Antiretroviral PI/NRTI combo alafenamide (DRV/COBI/FTC/TAF) dolutegravir (DTG) Tivicay Antiretroviral Integrase strand transfer inhibitor (INSTI) dolutegravir / lamivudine (DTG/3TC) Dovato Antiretroviral INSTI/NRTI combo dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) Triumeq Antiretroviral INSTI/NRTI combo dolutegravir/rilpivirine (DTG/RPV) Juluca
    [Show full text]
  • Medication Guide for a Safe Recovery
    Medication Guide For A Safe Recovery A guide to maintaining sobriety while receiving treatment for other health problems. Revision 1.0 -April 2008 Table of Contents Introduction..................................................................................2 How to Use this Guide..................................................................3 Class A Drugs (Absolutely Avoid)................................................4 Class B Drugs................................................................................8 (With Addiction Medicine Specialist/Doctor Approval Only) Class C Drugs (Generally Safe to Take).....................................12 Alcohol-Free Products..................................................................16 Incidental Exposure Index...........................................................22 www.talbottcampus.com Introduction From the Talbott Recovery Campus Welcome to the Talbott Recovery Campus guide for a safe and sustained recovery. This document was developed through a collaborative effort between some of the best minds in addiction care today and will help you make wise decisions, ensuring that medications you may be prescribed and incidental exposure to alcohol do not threaten your hard won recovery. This guide is divided into three sections and is based on the drug classification system developed nearly 20 years ago by Dr. Paul Earley and recently expanded on by Bruce Merkin, M.D., Renee Enstrom, Nicholas Link and the staff at Glenbeigh hospital. Part one provides a way of categorizing medications
    [Show full text]
  • Cyproheptadine for Central Hypertension?
    OPEN ACCESS Research article Cyproheptadine for central hypertension? Guido Filler1,2,*, Lara Hart1, April Chan3, Elizabeth Cairney4, Asuri N Prasad5 1Department of Paediatrics, Division of Paediatric Nephrology, Schulich School ABSTRACT of Medicine & Dentistry, London, ON, Background: Approximately one-fifth of paediatric intracranial tumors result in hypertension. Canada N6A 5W9 2Department of Pathology and The condition is difficult to treat in this population, particularly if it is refractory, since there is little Laboratory Medicine, Schulich School of guidance on patient management beyond first-line therapy with IV labetalol. Medicine & Dentistry, University of Western Ontario, London, Ontario, Methods: A 20-month-old patient was hospitalized with cerebral herniation-induced loss of Canada N5A 5A5 consciousness and a posterior fossa mass was found. Although several first-line treatments including 3 School of Pharmacy, University of IV labetalol, furosemide, amlodipine, clonidine, and atenolol were administered, the patient’s Western Ontario, London, ON, Canada 5A 5A5 hypertension persisted. With few options left, positive findings from previously published case reports 4Department of Paediatrics, Division of led the team to administer cyproheptadine. Hematology/Oncology, Schulich School of Medicine & Dentistry, London, ON, Results: Cyproheptadine resulted in improved blood pressure and allowed for a dose reduction in Canada N6A 5W9 other antihypertensives, but elevated liver transaminases and suspected hepatotoxicity several weeks 5 Department of Paediatrics, Division of later resulted in the discontinuation of this treatment. Neurology, Schulich School of Medicine & Dentistry, London, ON, Canada N6A Conclusions: Despite the safety concerns associated with using cyproheptadine to treat paediatric 5W9 central hypertension, this treatment holds promise for persistent refractory hypertension as a last-line *Email: [email protected] agent when all other treatment options are exhausted.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2006) – Supplement 1 (Rev. 1) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABACAVIR 136470-78-5 ACEXAMIC ACID 57-08-9 ABAFUNGIN 129639-79-8 ACICLOVIR 59277-89-3 ABAMECTIN 65195-55-3 ACIFRAN 72420-38-3 ABANOQUIL 90402-40-7 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABCIXIMAB 143653-53-6 ACITEMATE 101197-99-3 ABECARNIL 111841-85-1 ACITRETIN 55079-83-9 ABIRATERONE 154229-19-3 ACIVICIN 42228-92-2 ABITESARTAN 137882-98-5 ACLANTATE 39633-62-0 ABLUKAST 96566-25-5 ACLARUBICIN 57576-44-0 ABUNIDAZOLE 91017-58-2 ACLATONIUM NAPADISILATE 55077-30-0 ACADESINE 2627-69-2 ACODAZOLE 79152-85-5 ACAMPROSATE 77337-76-9 ACONIAZIDE 13410-86-1 ACAPRAZINE 55485-20-6 ACOXATRINE 748-44-7 ACARBOSE 56180-94-0 ACREOZAST 123548-56-1 ACEBROCHOL 514-50-1 ACRIDOREX 47487-22-9 ACEBURIC
    [Show full text]